Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C G Bridges

Showing results (11-20 of 24) with videos related to

Pageof 3
Sort By:
Journal of Interferon Research|August 1, 1989
Equine interferons following exposure to equid herpesvirus-1 or -4N Edington, C G Bridges, L Griffiths
Tierarztliche Praxis. Supplement|January 1, 1987
Rapid diagnosis and characterization of equid herpesvirus 1 using monoclonal antibodiesN Edington, C G Bridges, S C Broad
Archives of Virology|January 1, 1986
Endothelial cell infection and thrombosis in paralysis caused by equid herpesvirus-1: equine strokeN Edington, C G Bridges, J R Patel
Clinical and Experimental Immunology|November 1, 1980
A radiometric assay for the combined measurement of phagocytosis and intracellular killing of Candida albicansC G Bridges, G L Dasilva, M Yamamura, et al.
The Journal of General Virology|February 1, 1992
Latent equid herpesviruses 1 and 4: detection and distinction using the polymerase chain reaction and co-cultivation from lymphoid tissuesH M Welch, C G Bridges, A M Lyon, et al.
Antiviral Research|October 1, 1994
The prevention of cell adhesion and the cell-to-cell spread of HIV-1 in vitro by the alpha-glucosidase 1 inhibitor, 6-O-butanoyl castanospermine (MDL 28574)C G Bridges, T M Brennan, D L Taylor, et al.
Antiviral Research|March 1, 1995
The inhibition of human immunodeficiency virus type 1 in vitro by a non-nucleoside reverse transcriptase inhibitor MKC-442, alone and in combination with other anti-HIV compoundsT M Brennan, D L Taylor, C G Bridges, et al.
Antiviral Research|August 1, 1995
The ribonucleotide reductase inhibitor (E)-2'-fluoromethylene-2'-deoxycytidine (MDL 101,731): a potential topical therapy for herpes simplex virus infectionC G Bridges, S P Ahmed, P S Sunkara, et al.
Glycobiology|March 1, 1995
Treatment with the alpha-glucosidase 1 inhibitor 6-O-butanoyl castanospermine reduces the detection of LFA-1 (CD18/CD11a) by monoclonal antibodiesC G Bridges, D L Taylor, M S Kang, et al.
Antimicrobial Agents and Chemotherapy|August 1, 1994
Inhibition of alpha-glucosidase I of the glycoprotein-processing enzymes by 6-O-butanoyl castanospermine (MDL 28,574) and its consequences in human immunodeficiency virus-infected T cellsD L Taylor, M S Kang, T M Brennan, et al.
Pageof 3

Showing results (11-20 of 24) with videos related to

Sort By:
Pageof 3
Journal of Interferon Research|August 1, 1989
Equine interferons following exposure to equid herpesvirus-1 or -4N Edington, C G Bridges, L Griffiths
Tierarztliche Praxis. Supplement|January 1, 1987
Rapid diagnosis and characterization of equid herpesvirus 1 using monoclonal antibodiesN Edington, C G Bridges, S C Broad
Archives of Virology|January 1, 1986
Endothelial cell infection and thrombosis in paralysis caused by equid herpesvirus-1: equine strokeN Edington, C G Bridges, J R Patel
Clinical and Experimental Immunology|November 1, 1980
A radiometric assay for the combined measurement of phagocytosis and intracellular killing of Candida albicansC G Bridges, G L Dasilva, M Yamamura, et al.
The Journal of General Virology|February 1, 1992
Latent equid herpesviruses 1 and 4: detection and distinction using the polymerase chain reaction and co-cultivation from lymphoid tissuesH M Welch, C G Bridges, A M Lyon, et al.
Antiviral Research|October 1, 1994
The prevention of cell adhesion and the cell-to-cell spread of HIV-1 in vitro by the alpha-glucosidase 1 inhibitor, 6-O-butanoyl castanospermine (MDL 28574)C G Bridges, T M Brennan, D L Taylor, et al.
Antiviral Research|March 1, 1995
The inhibition of human immunodeficiency virus type 1 in vitro by a non-nucleoside reverse transcriptase inhibitor MKC-442, alone and in combination with other anti-HIV compoundsT M Brennan, D L Taylor, C G Bridges, et al.
Antiviral Research|August 1, 1995
The ribonucleotide reductase inhibitor (E)-2'-fluoromethylene-2'-deoxycytidine (MDL 101,731): a potential topical therapy for herpes simplex virus infectionC G Bridges, S P Ahmed, P S Sunkara, et al.
Glycobiology|March 1, 1995
Treatment with the alpha-glucosidase 1 inhibitor 6-O-butanoyl castanospermine reduces the detection of LFA-1 (CD18/CD11a) by monoclonal antibodiesC G Bridges, D L Taylor, M S Kang, et al.
Antimicrobial Agents and Chemotherapy|August 1, 1994
Inhibition of alpha-glucosidase I of the glycoprotein-processing enzymes by 6-O-butanoyl castanospermine (MDL 28,574) and its consequences in human immunodeficiency virus-infected T cellsD L Taylor, M S Kang, T M Brennan, et al.
Pageof 3